🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to test the safety and efficacy of a ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-02-02
Trial ID
NCT07148180
Treatments Being Tested
This phase I/II trial studies the side effects, best dose, and effect of ta...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-03-04
Trial ID
NCT05038592
Treatments Being Tested
The main goal of this registry study is to investigate the effectiveness an...
Status
Recruiting
Location
Medical University Innsbruck
Start Date
2024-06-26
Trial ID
NCT07785154
Treatments Being Tested
This study will be divided into 2 parts (Part 1 and Part 2). Part 1 will ev...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2025-01-14
Trial ID
NCT06456463
Treatments Being Tested
This is a non-randomized, open-label, multicenter, dose escalation study de...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2015-02
Trial ID
NCT02270463
Treatments Being Tested
A treatment cycle is 28 days. Tagraxofusp will be administered at 9 mcg/kg ...
Status
Recruiting
Location
University of Miami
Start Date
2024-05-01
Trial ID
NCT05442216
Treatments Being Tested
The goal of this open-label, single-center, pilot trial is to test the comb...
Status
Recruiting
Location
The University of Kansas Cancer Center
Start Date
2025-08-25
Trial ID
NCT06414681
Treatments Being Tested
This phase Ib/II trial tests the safety of tagraxofusp when given with or w...
Status
Withdrawn
Location
Habtemariam,Bruck
Start Date
2024-08-03
Trial ID
NCT05720988
Treatments Being Tested
This phase II trial studies how well venetoclax, SL-401, and chemotherapy w...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-05-29
Trial ID
NCT04216524
Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin re...
Status
Recruiting
Location
Children's Hospital Los Angeles
Start Date
2022-11-11
Trial ID
NCT05476770